Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.033 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
30-Mar-2018Antiapoptotic BCL-2 proteins determine Sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinomaTutusaus, Anna; Stefanovic, Milica; Boix i Ferrero, Loreto; Cucarull, Blanca; Zamora, Aynara; Blasco, Laura; García de Frutos, Pablo; Reig, María; Fernández-Checa Torres, José Carlos; Marí García, Montserrat; Colell Riera, Anna; Bruix Tudó, Jordi; Morales Muñoz, Albert
26-Jan-2022Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic AdvancesCucarull, Blanca; Tutusaus, Anna; Rider, Patricia; Hernáez Alsina, Tania; Cuño, Carlos; Garcia de Frutos, Pablo; Colell, Anna; Mari, Montserrat; Morales, Albert
4-Mar-2022Epidemiology of Melanoma in Spain: Estimation of Number of Patients With Stage III Disease Eligible for Adjuvant TherapiesPuig Sarda, Susana; Martínez Fernández, A.; Nagore, Eduardo; Moreno Ramírez, David; Ortiz Romero, Pablo L.; Martín Sánchez , Eva; Puig Sarda, Susana
9-Dec-2022Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancerFalato, Claudette; Schettini, Francesco; Pascual, Tomás; Brasó Maristany, Fara; Prat Aparicio, Aleix
27-Oct-2022Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain studyPérez García, José Manuel, 1944-; Gebhart, Geraldine; Borrego, Manuel Ruiz; Schmid, Peter; Marmé, Frederik; Prat Aparicio, Aleix; Dalenc, Florence; Kerrou, Khaldoun; Colleoni, Marco; Braga, Sofía; Malfettone, Andrea; Sampayo Cordero, Miguel; Cortes, Javier; Llombart Cussac, Antonio
6-Nov-2022Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic TestsSaponaro, Mariarosaria; Annunziata, Luigi; Turla, Antonella; Viganò, Ilaria; Laurentiis, Michele De; Giuliano, Mario; Mastro, Lucia del; Montemurro, Filippo; Puglisi, Fabio; Angelis, Carmine De; Buono, Giuseppe; Schettini, Francesco; Arpino, Grazia
23-Aug-2022Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel AgentsGarufi, Giovanna; Carbognin, Luisa; Schettini, Francesco; Seguí, Elia; Di Leone, Alba; Franco, Antonio; Paris, Ida; Scambia, Giovanni; Tortora, Giampaolo; Fabi, Alessandra
1-Jan-2023Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectivesSirico, Marianna; Virga, Alessandra; Conte, Benedetta; Urbini, Milena; Ulivi, Paola; Gianni, Caterina; Merloni, Filippo; Palleschi, Michela; Gasperoni, Marco; Curcio, Annalisa; Saha, Debjani; Buono, Giuseppe; Muñoz, Montserrat; De Giorgi, Ugo; Schettini, Francesco
3-Jan-2022Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancerPrat Aparicio, Aleix; Guarneri, Valentina; Pascual, Tomás; Brasó Maristany, Fara; Sanfeliu, Esther; Paré Brunet, Laia; Schettini, Francesco; Martínez, Debora; Jares Gerboles, Pedro; Griguolo, Gaia; Dieci, Maria Vittoria; Cortés, Javier; Llombart Cussac, Antonio; Conte, Benedetta; Marín Aguilera, Mercedes; Chic Ruché, Núria; Puig Butillé, Joan Anton; Martínez, Antonio; Galván, Patricia; Tsai, Yi-Hsuan; González Farré, Blanca; Mira, Aurea; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S.; Conte, Pierfranco; Perou, Charles M.